Elizabeth Oestriech
Eliquent Life Sciences
Elizabeth Oestreich is a Senior Vice President of Regulatory Compliance at Eliquent Life Sciences. She has particular expertise in two of the FDA’s newest regulated product categories; tobacco and cannabis-derived products. Liz advises clients navigating the regulatory landscape for tobacco products and assists with content and format of applications, interpretation of FDA regulation, engagement with the FDA, and policy development. Liz is well versed in the regulatory barriers facing the rapidly growing cannabis industry. She offers strategic guidance and risk-based strategies to CBD manufacturers and distributors as the FDA contemplates how to regulate the product category.
